Login / Signup

Glycemic Variability With Insulin Glargine Versus Detemir in Hospitalized Patients With Diabetes.

Jamie GeorgeChristopher Alan GiulianoCarrie L Hartner
Published in: Journal of pharmacy practice (2021)
Insulin detemir exhibited less GV than insulin glargine, although the small difference is unlikely to be clinically significant. Application of this data will aid in formulary decisions and support the use of either agent within the hospital setting.
Keyphrases
  • glycemic control
  • type diabetes
  • healthcare
  • weight loss
  • insulin resistance
  • electronic health record
  • big data
  • adverse drug
  • machine learning
  • deep learning
  • data analysis